Cryo Cell International (CCEL) Return on Capital Employed (2011 - 2026)

Cryo Cell International has disclosed Return on Capital Employed across 16 years of filings, most recently posting 0.44% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 148.0% year-over-year to 0.44%; the TTM figure through Feb 2026 stood at 0.44% (down 148.0% YoY), while the FY2025 annual figure was 1.11%, down 26.0% from the prior year.
• Return on Capital Employed fell to 0.44% in Q1 2026, from 1.13% in the prior quarter.
• Over the last five years, Return on Capital Employed for CCEL reached as high as 3.17% in Q3 2025 and fell as low as 30.04% in Q1 2024.
• The 5-year median for Return on Capital Employed is 1.4% (2024), against an average of 5.71%.
• Annual changes were most pronounced in 2024 — Return on Capital Employed plunged 3200 bps — and 2025, when it surged 3216 bps.
• A 5-year view of Return on Capital Employed shows it stood at 1.5% in 2022, then tumbled by 1864 bps to 26.53% in 2023, then surged by 105 bps to 1.4% in 2024, then retreated by 19 bps to 1.13% in 2025, then sank by 61 bps to 0.44% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 0.44%, 1.13%, and 3.17% for Q1 2026, Q4 2025, and Q3 2025 respectively.